ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR

Yan, Jun; Xu, Yuzhu; Jin, Xing; Zhang, Qiaoxuan; Ouyang, Feng; Han, Liqiao; Zhan, Min; Li, Xingshu; Liang, Baoxia*; Huang, Xianzhang*广州中医药大学; 中山大学
European Journal of Medicinal Chemistry2022-1-5DOI: 10.1016/j.ejmech.2021.113897
13被引8阅读
引用收藏
分享

摘要

Microtubule target agents (MTAs) are widely-used clinical anti-cancer drugs for decades, but the acquired drug resistance severely restricted their application. Thioredoxin reductases (TrxR) was reported to be overexpressed in most tumors and closely related to high risk of cancer recurrence and drug resistance, making it a potential target for anticancer drug discovery. Multi-target-directed ligands (MTDLs) by a single molecule provide a logical and alternative approach to drug combinations. In this work, based on the structure-activity relationships obtained in our previous study, some structure modifications were performed. On one hand, the retained skeleton structure of MTAs endowed its tubulin polymerization inhibition activity, on the other hand, the selenium-containing structure and alpha,beta-unsaturated ketone moiety endowed the TrxR inhibition activity. As results, the newly obtained compounds exhibited superior anti-proliferative activities towards various human cancer cells and drugresistance cells, and displayed high selectivity towards various human normal cells. The mechanism study revealed that the dual effect of cell cycle arrest triggered by targeting tubulin and the abnormal accumulation of ROS caused by TrxR inhibition eventually lead to cell apoptosis. Notably, compared with the MTA agents CA-4P, and the TrxR inhibitor Ethaselen, the optimized compound 14c, which served as dual-targeting inhibitor of tubulin and TrxR, exerted greatly improved in vivo anti-tumor activity. In summary, 14c deserved further consideration for cancer therapy.

学科与关键词

关键词
Microtubule targeting agentsTrxRAnti-tumor activityDual-targeting inhibitor
相关
加载中…
  • Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR
    Hu, Jinhui*; Chen, Li; Lu, Zhonghui; Yao, Han; Hu, Yunfei; Feng, Luanqi; Pang, Yanqing; Wu, Jia-Qiang; Yu, Zhiling; Chen, Wen-Hua*MOLECULES, 2023, 28(3): 1304.被引 1
  • Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anticancer activity
    Yang, Fang; Jian, Xie-Er; Chen, Lin; Ma, Yu-Feng; Liu, Yu-Xia; You, Wen-Wei; Zhao, Pei-Liang*New Journal of Chemistry, 2021, 45(46): 21869-21880.被引 7
  • Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis
    Zhou, Jingwei; Pang, Yanqing; Zhang, Weiwei; OuYang, Fen; Lin, Haibiao; Li, Xingshu*; Yan, Jun*Journal of Medicinal Chemistry, 2022, 65(6): 4687-4708.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2022-01-05
卷期
第 227 卷
页码
113897
DOI
10.1016/j.ejmech.2021.113897
语言
MULTI-LANGUAGE
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [22007021, 21907017]; Science and Technology Planning Project of Guangzhou [202102010213, 202102010132]; Guangdong Natural Science Foundation [2018A030310186, 2020A1515010667]; Guangzhou Health and Family Planning Commission of Guangdong Province of China [20201A011080]

作者

  • Y

    Yan, Jun (第一作者)

    2 · guangzhou univ chinese med

  • X

    Xu, Yuzhu

    2 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • J

    Jin, Xing

    2 · guangzhou univ chinese med

  • Z

    Zhang, Qiaoxuan

    2 · guangzhou univ chinese med

  • O

    Ouyang, Feng

    2 · guangzhou univ chinese med

  • H

    Han, Liqiao

    2 · guangzhou univ chinese med

  • Z

    Zhan, Min

    2 · guangzhou univ chinese med

  • L

    Li, Xingshu

    sun yat sen univ

  • L

    Liang, Baoxia (通讯)

  • H

    Huang, Xianzhang (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417